New check can ID sufferers liable to extreme COVID-19, examine finds

New check can ID sufferers liable to extreme COVID-19, examine finds

A genomic check being developed by a Charlottesville, Va., firm can predict a affected person’s danger of creating extreme COVID-19, new analysis from UVA Health suggests. That data might assist docs determine sufferers at excessive danger for poor outcomes and rapidly start tailor-made remedy.

read more
Genomic tests help doctors treat COVID-19 and long COVID

Genomic tests help doctors treat COVID-19 and long COVID

With many COVID-19 treatments now available, a simple blood test can show doctors the best route to take. Charlottesville’s AMPEL BioSolutions says it can predict and detect the severity of a COVID-19 infection, as well as how to help a patient through its new genomic test called CovGENE.

read more
Test Can ID Patients at Risk for Severe COVID-19, Study Suggests

Test Can ID Patients at Risk for Severe COVID-19, Study Suggests

A genomic test being developed by a Charlottesville company can predict a patient’s risk of developing severe COVID-19, new research from UVA Health suggests. That information could help doctors identify patients at high risk for poor outcomes and quickly begin tailored treatment. 

read more
New Breakthrough Test Detects and Predicts Severity of COVID-19

New Breakthrough Test Detects and Predicts Severity of COVID-19

AMPEL BioSolutions today announced a breakthrough in precision and personalized medicine that can detect and predict the severity of COVID-19 in patients while also determining the best treatment options for each specific case. The company’s new approach, through a simple blood test, will ultimately accelerate the means of providing effective treatments to the right people at the right time and potentially stem the serious illness caused by SARS-CoV-2 infection that can lead to lung damage or death.

read more

Pin It on Pinterest